| Index | Ligand Name | Structure | PDB code | ligand desolvation |
| 1 | 8rn | Crystal structure of USP7 in complex with a potent, selective and reversible small-molecule inhibitor | 5n9r | 90.01 |
| 2 | 8jp | USP7 in complex with GNE6776 (6'-amino-4'-ethyl-5'-(4-hydroxyphenyl)-N-methyl-[3,3'-bipyridine]-6-carboxamide) | 5uqx | 87.1 |
| 3 | 8jm | USP7 in complex with GNE6640 (4-(2-amino-4-ethyl-5-(1H-indazol-5-yl)pyridin-3-yl)phenol) | 5uqv | 86.17 |
| 4 | 9qa | Structure of DUB complex | 5vsb | 85.79 |
| 5 | 8qq | Crystal structure of USP7 in complex with a potent, selective and reversible small-molecule inhibitor | 5n9t | 84.43 |
| 6 | cq5 | Crystal structure of USP7 in complex with a 4-hydroxypiperidine based inhibitor | 6f5h | 83.91 |
| 7 | 8wk | Crystal structure of USP7 in complex with the non-covalent inhibitor, FT671 | 5nge | 82.58 |
| 8 | ajj | USP7 in complex with Cpd2 (4-(3-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-5-yl)phenol) | 5whc | 79.95 |
| 9 | 8wn | Crystal structure of USP7 in complex with the covalent inhibitor, FT827 | 5ngf | 77.66 |
| 10 | 9qd | Structure of DUB complex | 5vs6 | 68.85 |